Report Cover

Global Gabapentin Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026


The Gabapentin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Gabapentin Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Gabapentin Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Gabapentin Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Capsule
    Tablet
    Oral Solution

Market segment by Application can be divided into
    Postherpetic Neuralgia in Adults
    Partial Onset Seizures
    Others

The key market players for global Gabapentin Drug market are listed below:
    Pfizer
    Depomed
    Apotex
    Teva
    Acella Pharmaceuticals
    Taro
    Sun Pharmaceutical
    Glenmark
    Amneal Pharmaceuticals
    Aurobindo Pharma
    Zydus Pharmaceuticals
    Hi-Tech Pharmaceuticals
    Marksans Pharma
    Mylan
    InvaGen Pharmaceuticals
    Alkem Laboratories
    Tris Pharma
    ACI HealthCare Limited
    Jiangsu Hengrui Medicine
    CSPC Ouyi Pharmaceutical
    Sciegen Pharmaceuticals
    Epic Pharma
    Lupin Limited

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Gabapentin Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gabapentin Drug, with price, sales, revenue and global market share of Gabapentin Drug from 2019 to 2021.
Chapter 3, the Gabapentin Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gabapentin Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Gabapentin Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Gabapentin Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Gabapentin Drug Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Gabapentin Drug Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Capsule
        1.2.3 Tablet
        1.2.4 Oral Solution
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Gabapentin Drug Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Postherpetic Neuralgia in Adults
        1.3.3 Partial Onset Seizures
        1.3.4 Others
    1.4 Global Gabapentin Drug Market Size & Forecast
        1.4.1 Global Gabapentin Drug Sales in Value (2016-2026))
        1.4.2 Global Gabapentin Drug Sales in Volume (2016-2026)
        1.4.3 Global Gabapentin Drug Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Gabapentin Drug Production Capacity Analysis
        1.5.1 Global Gabapentin Drug Total Production Capacity (2016-2026)
        1.5.2 Global Gabapentin Drug Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Gabapentin Drug Market Drivers
        1.6.2 Gabapentin Drug Market Restraints
        1.6.3 Gabapentin Drug Trends Analysis
2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Gabapentin Drug Product and Services
        2.1.4 Pfizer Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Depomed
        2.2.1 Depomed Details
        2.2.2 Depomed Major Business
        2.2.3 Depomed Gabapentin Drug Product and Services
        2.2.4 Depomed Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Apotex
        2.3.1 Apotex Details
        2.3.2 Apotex Major Business
        2.3.3 Apotex Gabapentin Drug Product and Services
        2.3.4 Apotex Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Teva
        2.4.1 Teva Details
        2.4.2 Teva Major Business
        2.4.3 Teva Gabapentin Drug Product and Services
        2.4.4 Teva Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Acella Pharmaceuticals
        2.5.1 Acella Pharmaceuticals Details
        2.5.2 Acella Pharmaceuticals Major Business
        2.5.3 Acella Pharmaceuticals Gabapentin Drug Product and Services
        2.5.4 Acella Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Taro
        2.6.1 Taro Details
        2.6.2 Taro Major Business
        2.6.3 Taro Gabapentin Drug Product and Services
        2.6.4 Taro Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Sun Pharmaceutical
        2.7.1 Sun Pharmaceutical Details
        2.7.2 Sun Pharmaceutical Major Business
        2.7.3 Sun Pharmaceutical Gabapentin Drug Product and Services
        2.7.4 Sun Pharmaceutical Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Glenmark
        2.8.1 Glenmark Details
        2.8.2 Glenmark Major Business
        2.8.3 Glenmark Gabapentin Drug Product and Services
        2.8.4 Glenmark Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Amneal Pharmaceuticals
        2.9.1 Amneal Pharmaceuticals Details
        2.9.2 Amneal Pharmaceuticals Major Business
        2.9.3 Amneal Pharmaceuticals Gabapentin Drug Product and Services
        2.9.4 Amneal Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Aurobindo Pharma
        2.10.1 Aurobindo Pharma Details
        2.10.2 Aurobindo Pharma Major Business
        2.10.3 Aurobindo Pharma Gabapentin Drug Product and Services
        2.10.4 Aurobindo Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Zydus Pharmaceuticals
        2.11.1 Zydus Pharmaceuticals Details
        2.11.2 Zydus Pharmaceuticals Major Business
        2.11.3 Zydus Pharmaceuticals Gabapentin Drug Product and Services
        2.11.4 Zydus Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Hi-Tech Pharmaceuticals
        2.12.1 Hi-Tech Pharmaceuticals Details
        2.12.2 Hi-Tech Pharmaceuticals Major Business
        2.12.3 Hi-Tech Pharmaceuticals Gabapentin Drug Product and Services
        2.12.4 Hi-Tech Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Marksans Pharma
        2.13.1 Marksans Pharma Details
        2.13.2 Marksans Pharma Major Business
        2.13.3 Marksans Pharma Gabapentin Drug Product and Services
        2.13.4 Marksans Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 Mylan
        2.14.1 Mylan Details
        2.14.2 Mylan Major Business
        2.14.3 Mylan Gabapentin Drug Product and Services
        2.14.4 Mylan Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.15 InvaGen Pharmaceuticals
        2.15.1 InvaGen Pharmaceuticals Details
        2.15.2 InvaGen Pharmaceuticals Major Business
        2.15.3 InvaGen Pharmaceuticals Gabapentin Drug Product and Services
        2.15.4 InvaGen Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.16 Alkem Laboratories
        2.16.1 Alkem Laboratories Details
        2.16.2 Alkem Laboratories Major Business
        2.16.3 Alkem Laboratories Gabapentin Drug Product and Services
        2.16.4 Alkem Laboratories Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.17 Tris Pharma
        2.17.1 Tris Pharma Details
        2.17.2 Tris Pharma Major Business
        2.17.3 Tris Pharma Gabapentin Drug Product and Services
        2.17.4 Tris Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.18 ACI HealthCare Limited
        2.18.1 ACI HealthCare Limited Details
        2.18.2 ACI HealthCare Limited Major Business
        2.18.3 ACI HealthCare Limited Gabapentin Drug Product and Services
        2.18.4 ACI HealthCare Limited Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.19 Jiangsu Hengrui Medicine
        2.19.1 Jiangsu Hengrui Medicine Details
        2.19.2 Jiangsu Hengrui Medicine Major Business
        2.19.3 Jiangsu Hengrui Medicine Gabapentin Drug Product and Services
        2.19.4 Jiangsu Hengrui Medicine Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.20 CSPC Ouyi Pharmaceutical
        2.20.1 CSPC Ouyi Pharmaceutical Details
        2.20.2 CSPC Ouyi Pharmaceutical Major Business
        2.20.3 CSPC Ouyi Pharmaceutical Gabapentin Drug Product and Services
        2.20.4 CSPC Ouyi Pharmaceutical Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.21 Sciegen Pharmaceuticals
        2.21.1 Sciegen Pharmaceuticals Details
        2.21.2 Sciegen Pharmaceuticals Major Business
        2.21.3 Sciegen Pharmaceuticals Gabapentin Drug Product and Services
        2.21.4 Sciegen Pharmaceuticals Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.22 Epic Pharma
        2.22.1 Epic Pharma Details
        2.22.2 Epic Pharma Major Business
        2.22.3 Epic Pharma Gabapentin Drug Product and Services
        2.22.4 Epic Pharma Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.23 Lupin Limited
        2.23.1 Lupin Limited Details
        2.23.2 Lupin Limited Major Business
        2.23.3 Lupin Limited Gabapentin Drug Product and Services
        2.23.4 Lupin Limited Gabapentin Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Gabapentin Drug Sales by Manufacturer
    3.1 Global Gabapentin Drug Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Gabapentin Drug Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Gabapentin Drug
    3.4 Market Concentration Rate
        3.4.1 Top 3 Gabapentin Drug Manufacturer Market Share
        3.4.2 Top 6 Gabapentin Drug Manufacturer Market Share
    3.5 Global Gabapentin Drug Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Gabapentin Drug Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Gabapentin Drug Market Size by Region
        4.1.1 Global Gabapentin Drug Sales in Volume by Region (2016-2026)
        4.1.2 Global Gabapentin Drug Revenue by Region (2016-2026)
    4.2 North America Gabapentin Drug Revenue (2016-2026)
    4.3 Europe Gabapentin Drug Revenue (2016-2026)
    4.4 Asia-Pacific Gabapentin Drug Revenue (2016-2026)
    4.5 South America Gabapentin Drug Revenue (2016-2026)
    4.6 Middle East and Africa Gabapentin Drug Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Gabapentin Drug Sales in Volume by Type (2016-2026)
    5.2 Global Gabapentin Drug Revenue by Type (2016-2026)
    5.3 Global Gabapentin Drug Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Gabapentin Drug Sales in Volume by Application (2016-2026)
    6.2 Global Gabapentin Drug Revenue by Application (2016-2026)
    6.3 Global Gabapentin Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Gabapentin Drug Sales by Type (2016-2026)
    7.2 North America Gabapentin Drug Sales by Application (2016-2026)
    7.3 North America Gabapentin Drug Market Size by Country
        7.3.1 North America Gabapentin Drug Sales in Volume by Country (2016-2026)
        7.3.2 North America Gabapentin Drug Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Gabapentin Drug Sales by Type (2016-2026)
    8.2 Europe Gabapentin Drug Sales by Application (2016-2026)
    8.3 Europe Gabapentin Drug Market Size by Country
        8.3.1 Europe Gabapentin Drug Sales in Volume by Country (2016-2026)
        8.3.2 Europe Gabapentin Drug Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Gabapentin Drug Sales by Type (2016-2026)
    9.2 Asia-Pacific Gabapentin Drug Sales by Application (2016-2026)
    9.3 Asia-Pacific Gabapentin Drug Market Size by Region
        9.3.1 Asia-Pacific Gabapentin Drug Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Gabapentin Drug Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Gabapentin Drug Sales by Type (2016-2026)
    10.2 South America Gabapentin Drug Sales by Application (2016-2026)
    10.3 South America Gabapentin Drug Market Size by Country
        10.3.1 South America Gabapentin Drug Sales in Volume by Country (2016-2026)
        10.3.2 South America Gabapentin Drug Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Gabapentin Drug Sales by Type (2016-2026)
    11.2 Middle East & Africa Gabapentin Drug Sales by Application (2016-2026)
    11.3 Middle East & Africa Gabapentin Drug Market Size by Country
        11.3.1 Middle East & Africa Gabapentin Drug Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Gabapentin Drug Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Gabapentin Drug Typical Distributors
    12.3 Gabapentin Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

List of Tables Table 1. Global Gabapentin Drug Revenue by Type, (USD Million), 2021-2026 Table 2. Global Gabapentin Drug Revenue by Application, (USD Million), 2021-2026 Table 3. Pfizer Basic Information, Manufacturing Base and Competitors Table 4. Pfizer Major Business Table 5. Pfizer Gabapentin Drug Product and Services Table 6. Pfizer Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 7. Depomed Basic Information, Manufacturing Base and Competitors Table 8. Depomed Major Business Table 9. Depomed Gabapentin Drug Product and Services Table 10. Depomed Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 11. Apotex Basic Information, Manufacturing Base and Competitors Table 12. Apotex Major Business Table 13. Apotex Gabapentin Drug Product and Services Table 14. Apotex Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 15. Teva Basic Information, Manufacturing Base and Competitors Table 16. Teva Major Business Table 17. Teva Gabapentin Drug Product and Services Table 18. Teva Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 19. Acella Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 20. Acella Pharmaceuticals Major Business Table 21. Acella Pharmaceuticals Gabapentin Drug Product and Services Table 22. Acella Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 23. Taro Basic Information, Manufacturing Base and Competitors Table 24. Taro Major Business Table 25. Taro Gabapentin Drug Product and Services Table 26. Taro Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 27. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors Table 28. Sun Pharmaceutical Major Business Table 29. Sun Pharmaceutical Gabapentin Drug Product and Services Table 30. Sun Pharmaceutical Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 31. Glenmark Basic Information, Manufacturing Base and Competitors Table 32. Glenmark Major Business Table 33. Glenmark Gabapentin Drug Product and Services Table 34. Glenmark Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 35. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 36. Amneal Pharmaceuticals Major Business Table 37. Amneal Pharmaceuticals Gabapentin Drug Product and Services Table 38. Amneal Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 39. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors Table 40. Aurobindo Pharma Major Business Table 41. Aurobindo Pharma Gabapentin Drug Product and Services Table 42. Aurobindo Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 43. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 44. Zydus Pharmaceuticals Major Business Table 45. Zydus Pharmaceuticals Gabapentin Drug Product and Services Table 46. Zydus Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 47. Hi-Tech Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 48. Hi-Tech Pharmaceuticals Major Business Table 49. Hi-Tech Pharmaceuticals Gabapentin Drug Product and Services Table 50. Hi-Tech Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 51. Marksans Pharma Basic Information, Manufacturing Base and Competitors Table 52. Marksans Pharma Major Business Table 53. Marksans Pharma Gabapentin Drug Product and Services Table 54. Marksans Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 55. Mylan Basic Information, Manufacturing Base and Competitors Table 56. Mylan Major Business Table 57. Mylan Gabapentin Drug Product and Services Table 58. Mylan Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 59. InvaGen Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 60. InvaGen Pharmaceuticals Major Business Table 61. InvaGen Pharmaceuticals Gabapentin Drug Product and Services Table 62. InvaGen Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 63. Alkem Laboratories Basic Information, Manufacturing Base and Competitors Table 64. Alkem Laboratories Major Business Table 65. Alkem Laboratories Gabapentin Drug Product and Services Table 66. Alkem Laboratories Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 67. Tris Pharma Basic Information, Manufacturing Base and Competitors Table 68. Tris Pharma Major Business Table 69. Tris Pharma Gabapentin Drug Product and Services Table 70. Tris Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 71. ACI HealthCare Limited Basic Information, Manufacturing Base and Competitors Table 72. ACI HealthCare Limited Major Business Table 73. ACI HealthCare Limited Gabapentin Drug Product and Services Table 74. ACI HealthCare Limited Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 75. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors Table 76. Jiangsu Hengrui Medicine Major Business Table 77. Jiangsu Hengrui Medicine Gabapentin Drug Product and Services Table 78. Jiangsu Hengrui Medicine Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 79. CSPC Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors Table 80. CSPC Ouyi Pharmaceutical Major Business Table 81. CSPC Ouyi Pharmaceutical Gabapentin Drug Product and Services Table 82. CSPC Ouyi Pharmaceutical Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 83. Sciegen Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table 84. Sciegen Pharmaceuticals Major Business Table 85. Sciegen Pharmaceuticals Gabapentin Drug Product and Services Table 86. Sciegen Pharmaceuticals Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 87. Epic Pharma Basic Information, Manufacturing Base and Competitors Table 88. Epic Pharma Major Business Table 89. Epic Pharma Gabapentin Drug Product and Services Table 90. Epic Pharma Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 91. Lupin Limited Basic Information, Manufacturing Base and Competitors Table 92. Lupin Limited Major Business Table 93. Lupin Limited Gabapentin Drug Product and Services Table 94. Lupin Limited Gabapentin Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e) Table 95. Global Gabapentin Drug Sales by Manufacturer (2019-2021e) & (K Units) Table 96. Global Gabapentin Drug Revenue by Manufacturer (2019-2021e) & (USD Million) Table 97. Market Position of Manufacturers in Gabapentin Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020 Table 98. Global Gabapentin Drug Production Capacity by Company, (K Units): 2020 VS 2021 Table 99. Head Office and Gabapentin Drug Production Site of Key Manufacturer Table 100. Gabapentin Drug New Entrant and Capacity Expansion Plans Table 101. Gabapentin Drug Mergers & Acquisitions in the Past Five Years Table 102. Global Gabapentin Drug Sales by Region (2016-2021e) & (K Units) Table 103. Global Gabapentin Drug Sales by Region (2021-2026) & (K Units) Table 104. Global Gabapentin Drug Revenue by Region (2016-2021e) & (USD Million) Table 105. Global Gabapentin Drug Revenue by Region (2021-2026) & (USD Million) Table 106. Global Gabapentin Drug Sales by Type (2016-2021e) & (K Units) Table 107. Global Gabapentin Drug Sales by Type (2021-2026) & (K Units) Table 108. Global Gabapentin Drug Revenue by Type (2016-2021e) & (USD Million) Table 109. Global Gabapentin Drug Revenue by Type (2021-2026) & (USD Million) Table 110. Global Gabapentin Drug Price by Type (2016-2021e) & (USD/Unit) Table 111. Global Gabapentin Drug Price by Type (2021-2026) & (USD/Unit) Table 112. Global Gabapentin Drug Sales by Application (2016-2021e) & (K Units) Table 113. Global Gabapentin Drug Sales by Application (2021-2026) & (K Units) Table 114. Global Gabapentin Drug Revenue by Application (2016-2021e) & (USD Million) Table 115. Global Gabapentin Drug Revenue by Application (2021-2026) & (USD Million) Table 116. Global Gabapentin Drug Price by Application (2016-2021e) & (USD/Unit) Table 117. Global Gabapentin Drug Price by Application (2021-2026) & (USD/Unit) Table 118. North America Gabapentin Drug Sales by Country (2016-2021e) & (K Units) Table 119. North America Gabapentin Drug Sales by Country (2021-2026) & (K Units) Table 120. North America Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million) Table 121. North America Gabapentin Drug Revenue by Country (2021-2026) & (USD Million) Table 122. North America Gabapentin Drug Sales by Type (2016-2021e) & (K Units) Table 123. North America Gabapentin Drug Sales by Type (2021-2026) & (K Units) Table 124. North America Gabapentin Drug Sales by Application (2016-2021e) & (K Units) Table 125. North America Gabapentin Drug Sales by Application (2021-2026) & (K Units) Table 126. Europe Gabapentin Drug Sales by Country (2016-2021e) & (K Units) Table 127. Europe Gabapentin Drug Sales by Country (2021-2026) & (K Units) Table 128. Europe Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million) Table 129. Europe Gabapentin Drug Revenue by Country (2021-2026) & (USD Million) Table 130. Europe Gabapentin Drug Sales by Type (2016-2021e) & (K Units) Table 131. Europe Gabapentin Drug Sales by Type (2021-2026) & (K Units) Table 132. Europe Gabapentin Drug Sales by Application (2016-2021e) & (K Units) Table 133. Europe Gabapentin Drug Sales by Application (2021-2026) & (K Units) Table 134. Asia-Pacific Gabapentin Drug Sales by Region (2016-2021e) & (K Units) Table 135. Asia-Pacific Gabapentin Drug Sales by Region (2021-2026) & (K Units) Table 136. Asia-Pacific Gabapentin Drug Revenue by Region (2016-2021e) & (USD Million) Table 137. Asia-Pacific Gabapentin Drug Revenue by Region (2021-2026) & (USD Million) Table 138. Asia-Pacific Gabapentin Drug Sales by Type (2016-2021e) & (K Units) Table 139. Asia-Pacific Gabapentin Drug Sales by Type (2021-2026) & (K Units) Table 140. Asia-Pacific Gabapentin Drug Sales by Application (2016-2021e) & (K Units) Table 141. Asia-Pacific Gabapentin Drug Sales by Application (2021-2026) & (K Units) Table 142. South America Gabapentin Drug Sales by Country (2016-2021e) & (K Units) Table 143. South America Gabapentin Drug Sales by Country (2021-2026) & (K Units) Table 144. South America Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million) Table 145. South America Gabapentin Drug Revenue by Country (2021-2026) & (USD Million) Table 146. South America Gabapentin Drug Sales by Type (2016-2021e) & (K Units) Table 147. South America Gabapentin Drug Sales by Type (2021-2026) & (K Units) Table 148. South America Gabapentin Drug Sales by Application (2016-2021e) & (K Units) Table 149. South America Gabapentin Drug Sales by Application (2021-2026) & (K Units) Table 150. Middle East & Africa Gabapentin Drug Sales by Country (2016-2021e) & (K Units) Table 151. Middle East & Africa Gabapentin Drug Sales by Country (2021-2026) & (K Units) Table 152. Middle East & Africa Gabapentin Drug Revenue by Country (2016-2021e) & (USD Million) Table 153. Middle East & Africa Gabapentin Drug Revenue by Country (2021-2026) & (USD Million) Table 154. Middle East & Africa Gabapentin Drug Sales by Type (2016-2021e) & (K Units) Table 155. Middle East & Africa Gabapentin Drug Sales by Type (2021-2026) & (K Units) Table 156. Middle East & Africa Gabapentin Drug Sales by Application (2016-2021e) & (K Units) Table 157. Middle East & Africa Gabapentin Drug Sales by Application (2021-2026) & (K Units) Table 158. Direct Channel Pros & Cons Table 159. Indirect Channel Pros & Cons Table 160. Gabapentin Drug Typical Distributors Table 161. Gabapentin Drug Typical Customers List of Figures Figure 1. Gabapentin Drug Picture Figure 2. Global Gabapentin Drug Sales Market Share by Type in 2020 Figure 3. Capsule Figure 4. Tablet Figure 5. Oral Solution Figure 6. Global Gabapentin Drug Sales Market Share by Application in 2020 Figure 7. Postherpetic Neuralgia in Adults Figure 8. Partial Onset Seizures Figure 9. Others Figure 10. Global Gabapentin Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026 Figure 11. Global Gabapentin Drug Market Size and Forecast (2016-2026) & (USD Million) Figure 12. Global Gabapentin Drug Sales (2016-2026) & (K Units) Figure 13. Global Gabapentin Drug Price by Type (2016-2026) & (USD/Unit) Figure 14. Global Gabapentin Drug Production Capacity (2016-2026) & (K Units) Figure 15. Global Gabapentin Drug Production Capacity by Geographic Region: 2020 VS 2021 Figure 16. Gabapentin Drug Market Drivers Figure 17. Gabapentin Drug Market Restraints Figure 18. Gabapentin Drug Market Trends Figure 19. Global Gabapentin Drug Sales Market Share by Manufacturer in 2020 Figure 20. Global Gabapentin Drug Revenue Market Share by Manufacturer in 2020 Figure 21. Gabapentin Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) Figure 22. Top 3 Gabapentin Drug Manufacturer (Revenue) Market Share in 2020 Figure 23. Top 6 Gabapentin Drug Manufacturer (Revenue) Market Share in 2020 Figure 24. Global Gabapentin Drug Sales Market Share by Region (2016-2026) Figure 25. Global Gabapentin Drug Revenue Market Share by Region (2016-2026) Figure 26. North America Gabapentin Drug Revenue (2016-2026) & (USD Million) Figure 27. Europe Gabapentin Drug Revenue (2016-2026) & (USD Million) Figure 28. Asia-Pacific Gabapentin Drug Revenue (2016-2026) & (USD Million) Figure 29. South America Gabapentin Drug Revenue (2016-2026) & (USD Million) Figure 30. Middle East & Africa Gabapentin Drug Revenue (2016-2026) & (USD Million) Figure 31. Global Gabapentin Drug Sales Market Share by Type (2016-2026) Figure 32. Global Gabapentin Drug Revenue Market Share by Type (2016-2026) Figure 33. Global Gabapentin Drug Price by Type (2016-2026) & (USD/Unit) Figure 34. Global Gabapentin Drug Sales Market Share by Application (2016-2026) Figure 35. Global Gabapentin Drug Revenue Market Share by Application (2016-2026) Figure 36. Global Gabapentin Drug Price by Application (2016-2026) & (USD/Unit) Figure 37. North America Gabapentin Drug Sales Market Share by Type (2016-2026) Figure 38. North America Gabapentin Drug Sales Market Share by Application (2016-2026) Figure 39. North America Gabapentin Drug Sales Market Share by Country (2016-2026) Figure 40. North America Gabapentin Drug Revenue Market Share by Country (2016-2026) Figure 41. United States Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 42. Canada Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 43. Mexico Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 44. Europe Gabapentin Drug Sales Market Share by Type (2016-2026) Figure 45. Europe Gabapentin Drug Sales Market Share by Application (2016-2026) Figure 46. Europe Gabapentin Drug Sales Market Share by Country (2016-2026) Figure 47. Europe Gabapentin Drug Revenue Market Share by Country (2016-2026) Figure 48. Germany Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. France Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. United Kingdom Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 51. Russia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 52. Italy Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 53. Asia-Pacific Gabapentin Drug Sales Market Share by Region (2016-2026) Figure 54. Asia-Pacific Gabapentin Drug Sales Market Share by Application (2016-2026) Figure 55. Asia-Pacific Gabapentin Drug Sales Market Share by Region (2016-2026) Figure 56. Asia-Pacific Gabapentin Drug Revenue Market Share by Region (2016-2026) Figure 57. China Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Japan Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 59. Korea Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 60. India Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 61. Southeast Asia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. Australia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. South America Gabapentin Drug Sales Market Share by Type (2016-2026) Figure 64. South America Gabapentin Drug Sales Market Share by Application (2016-2026) Figure 65. South America Gabapentin Drug Sales Market Share by Country (2016-2026) Figure 66. South America Gabapentin Drug Revenue Market Share by Country (2016-2026) Figure 67. Brazil Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 68. Argentina Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 69. Middle East & Africa Gabapentin Drug Sales Market Share by Type (2016-2026) Figure 70. Middle East & Africa Gabapentin Drug Sales Market Share by Application (2016-2026) Figure 71. Middle East & Africa Gabapentin Drug Sales Market Share by Country (2016-2026) Figure 72. Middle East & Africa Gabapentin Drug Revenue Market Share by Country (2016-2026) Figure 73. Turkey Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 74. Egypt Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 75. Saudi Arabia Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. South Africa Gabapentin Drug Revenue and Growth Rate (2016-2026) & (USD Million) Figure 77. Sales Channel: Direct Channel vs Indirect Channel Figure 78. Methodology Figure 79. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us